Overview
- 1 FDA inspection is on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2022-04-15.
At a glance
Inspections
1
Form 483s
1
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 30 Mar 2022 – 15 Apr 2022 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
15 Apr 2022
21 CFR 211.160(b)(4)
Calibration - at intervals, written program, remedial action
Cited by Taichun Qin, James B Arnett
15 Apr 2022
21 CFR 211.165(a)
Testing and release for distribution
Cited by Taichun Qin, James B Arnett
15 Apr 2022
FDCA 501(a)(2)(A)
Hazardous drugs, prevention of cross-contamination
Cited by Taichun Qin, James B Arnett
Investigators
FDA investigators tied to this site in the record.
Taichun Qin1 insp.
James B Arnett1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| FDCA 501(a)(2)(A) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Lynn Oaks Compounding Pharmacy's 1 Form 483
Recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat